Food-derived α-glucosidase inhibitory peptides
have gained
significant interest in treating type 2 diabetes mellitus (T2DM) owing
to their favorable safety profiles. Molecular docking combined with
molecular dynamics simulation was performed to screen α-glucosidase
inhibitory peptides from Ginkgo biloba seed cake
(GBSC), and two novel peptides (Met-Pro-Gly-Pro-Pro (MPGPP) and Phe-Ala-Pro-Ser-Trp
(FAPSW)) were acquired. The results of molecular docking and molecular
dynamics simulation suggested that FAPSW and MPGPP could generate
stable complexes with 3wy1, and the electrostatic and van der Waals
forces played contributory roles in FAPSW and MPGPP binding to 3wy1.
The α-glucosidase inhibition assay corroborated that FAPSW and
MPGPP had good α-glucosidase inhibition capacity, with IC50 values of 445.34 ± 49.48 and 1025.68 ± 140.78
μM, respectively. In vitro simulated digestion
results demonstrated that FAPSW and MPGPP strongly resisted digestion.
These findings lay a theoretical foundation for FAPSW and MPGPP in
treating T2DM.